Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Colorectal Neoplasms

Free Subscription Articles published in Ann Surg Oncol Retrieve available abstracts of 199 articles: HTML format

Single Articles

August 2025
1. BADER JM, Ospina A, Liu S, Reddy B, et al
   A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for Appendiceal and Colorectal Adenocarcinoma with Peritoneal Metastasis.
   Ann Surg Oncol. 2025;32:5784-5794.
   PubMed     Abstract available
   
   
   
2. TONELLO M, Cenzi C, Pizzolato E, Martini M, et al
   National Guidelines for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Malignancies: A Worldwide Systematic Review and Recommendations of Strength Analysis.
   Ann Surg Oncol. 2025;32:5795-5806.
   PubMed     Abstract available
   
   
   
3. WANG LJ, Bao Q, Wang HW, Huang LF, et al
   Predictive Factors for Chemotherapy Response in Colorectal Liver Metastasis: A Retrospective Study Utilizing Next-Generation Sequencing.
   Ann Surg Oncol. 2025;32:6067-6079.
   PubMed     Abstract available
   
   
   
4. LINDENLAUB F, Asenbaum U, Schwarz C, Makolli J, et al
   Total Metastases Volume and Relative Volume Reduction After Neoadjuvant Therapy Predict Outcome After Liver Resection of Colorectal Liver Metastases.
   Ann Surg Oncol. 2025;32:5667-5674.
   PubMed     Abstract available
   
   
   
5. GOHDA Y, Yano H, Suda R, Mirnezami A, et al
   Repeat Diagnostic Laparoscopy After Chemotherapy is Useful in Patient Selection for Conversion to Cytoreductive Surgery for Initially Unresectable Colorectal and Appendiceal Peritoneal Metastases: A Retrospective Cohort Study.
   Ann Surg Oncol. 2025;32:5774-5783.
   PubMed     Abstract available
   
   
   July 2025
6. KHALIL M, Pawlik TM
   ASO Author Reflections: The Hidden Burden: Impact of Allostatic Load on Colorectal Cancer Surgery Outcomes.
   Ann Surg Oncol. 2025 Jul 3. doi: 10.1245/s10434-025-17754.
   PubMed    
   
   
   
7. RAICHURKAR P, Brown KGM, White K, Koh CE, et al
   Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases: A Qualitative Exploration of the Lived Experiences of Patients and Carers.
   Ann Surg Oncol. 2025;32:5042-5050.
   PubMed     Abstract available
   
   
   
8. PEREZ RO, Vailati BB, Sao Juliao GP, Mazzucato F, et al
   The Landmark Series: Organ Preservation in Rectal Cancer-The Watch and Wait Strategy.
   Ann Surg Oncol. 2025;32:4945-4956.
   PubMed     Abstract available
   
   
   
9. BUNJO Z, Sammour T
   The Landmark Series: Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
   Ann Surg Oncol. 2025;32:4935-4944.
   PubMed     Abstract available
   
   
   
10. ZIVANOV CN, Kau NS, Nalluri-Butz H, Oduyale OK, et al
    Nonoperative Management of Rectal Cancer: Is "Near-Complete" Response Safe to Surveil?
    Ann Surg Oncol. 2025;32:4922-4930.
    PubMed     Abstract available
    
    
    June 2025
11. SCHULTZ KS, Bansal VV, Wach MM, Bhutiani N, et al
    Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases.
    Ann Surg Oncol. 2025 Jun 25. doi: 10.1245/s10434-025-17363.
    PubMed     Abstract available
    
    
    
12. SASSUN R, Sileo A, Ng JC, Brucchi F, et al
    ASO Visual Abstract: Oncological Outcomes of Neoadjuvant Chemotherapy Versus Upfront Surgery in Locally Advanced Colon Cancer: A Systematic Review, Meta-analysis, and Sequential Analysis.
    Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17722.
    PubMed    
    
    
    
13. KHALIL M, Woldesenbet S, Rashid Z, Altaf A, et al
    The Hidden Burden: Impact of Allostatic Load on Colorectal Cancer Surgery Outcomes.
    Ann Surg Oncol. 2025 Jun 21. doi: 10.1245/s10434-025-17711.
    PubMed     Abstract available
    
    
    
14. TODESCHINI L, Hernandez S, Maker AV
    ASO Author Reflections: Precision Immunoprofiling of the Tumor Microenvironment Predicts Recurrence in Advanced Colorectal Cancer.
    Ann Surg Oncol. 2025 Jun 17. doi: 10.1245/s10434-025-17728.
    PubMed    
    
    
    
15. SASSUN R, Sileo A, Ng JC
    ASO Author Reflections: Toward a New Standard: The Role of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer.
    Ann Surg Oncol. 2025 Jun 12. doi: 10.1245/s10434-025-17677.
    PubMed    
    
    
    
16. SASSUN R, Sileo A, Ng JC, Brucchi F, et al
    Oncological Outcomes of Neoadjuvant Chemotherapy Versus Upfront Surgery in Locally Advanced Colon Cancer: A Systematic Review, Meta-Analysis, and Sequential Analysis.
    Ann Surg Oncol. 2025 Jun 12. doi: 10.1245/s10434-025-17640.
    PubMed     Abstract available
    
    
    
17. SHIMIZU H, Kurashima K, Fukami T, Shiozaki A, et al
    Functional Analysis and Clinical Significance of Glutaredoxin 2 in Colon Cancer.
    Ann Surg Oncol. 2025 Jun 5. doi: 10.1245/s10434-025-17404.
    PubMed     Abstract available
    
    
    
18. TSAGKALIDIS V, Handorf EA, Bates BA, Brauer DG, et al
    ASO Visual Abstract: Estimating the Survival Impact of Curative-Intent Liver Therapies for Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2025 Jun 5. doi: 10.1245/s10434-025-17620.
    PubMed    
    
    
    
19. SHIMIZU H, Kurashima K, Fukami T, Shiozaki A, et al
    ASO Visual Abstract: Functional Analysis and Clinical Significance of Glutaredoxin 2 in Colon Cancer.
    Ann Surg Oncol. 2025 Jun 3. doi: 10.1245/s10434-025-17582.
    PubMed    
    
    
    
20. TAQI K, Icchhpuniani S, Stockley C, Elmi Assadzadeh G, et al
    ASO Visual Abstract: Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS & HIPEC) and Liver-Directed Therapy for Synchronous Peritoneal and Liver Metastatic Colorectal Cancer: A Systematic Review with Meta-analysis.
    Ann Surg Oncol. 2025 Jun 2. doi: 10.1245/s10434-025-17569.
    PubMed    
    
    
    
21. VAN KESTEREN LJ, Moolenaar LR, Nieuwenhuijzen JA, de Bruijn V, et al
    Double-Barrel Urocolostomy After Pelvic Exenteration: Short-Term Morbidity and Patient-Reported Quality of Life.
    Ann Surg Oncol. 2025;32:4534-4541.
    PubMed     Abstract available
    
    
    
22. JIRATHANIRUANGKIT K, Sainont G, Malakorn S
    Stepwise Approach for Robotic Total Pelvic Exenteration with En Bloc Presacral Fascia in T4b Rectal Cancer.
    Ann Surg Oncol. 2025;32:4250-4251.
    PubMed     Abstract available
    
    
    
23. KIM SJ, Shen C, Moheb ME, Cummins KC, et al
    Sociodemographic Disparities in Rectal Cancer Outcomes within Academic Cancer Centers.
    Ann Surg Oncol. 2025;32:3889-3899.
    PubMed     Abstract available
    
    
    
24. LAPERGOLA A, Melani AG, D'Urso A, Reitano E, et al
    Laparoscopic Oncologic Splenic Flexure Resection: A Complete Mesocolic Excision with Concomitant Inferior Mesenteric Artery and Vein Preservation.
    Ann Surg Oncol. 2025;32:4252-4255.
    PubMed     Abstract available
    
    
    
25. MERKOW RP, Cavnar MJ, Gleisner AL, Mayo SC, et al
    Minimum Requirements to Safely Establish and Sustain New Hepatic Arterial Infusion Pump Programs: An International Expert Perspective.
    Ann Surg Oncol. 2025;32:4408-4416.
    PubMed     Abstract available
    
    
    May 2025
26. LOEHRER AP, Wang Q, O'Malley AJ, Wong SL, et al
    ASO Visual Abstract: Influence of Medicaid Expansion on Rural Medicare Beneficiaries Undergoing Colon-Cancer-Directed Surgery in the United States.
    Ann Surg Oncol. 2025 May 31. doi: 10.1245/s10434-025-17469.
    PubMed    
    
    
    
27. TSAGKALIDIS V, Handorf EA, Bates BA, Brauer DG, et al
    Estimating the Survival Impact of Curative-Intent Liver Therapies for Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2025 May 22. doi: 10.1245/s10434-025-17486.
    PubMed     Abstract available
    
    
    
28. TAQI K, Icchhpuniani S, Stockley C, Assadzadeh GE, et al
    Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) and Liver-Directed Therapy for Synchronous Peritoneal and Liver Metastatic Colorectal Cancer: A Systematic Review with Meta-analysis.
    Ann Surg Oncol. 2025 May 15. doi: 10.1245/s10434-025-17321.
    PubMed     Abstract available
    
    
    
29. BHUTIANI N, Ochiai K, Peacock O, You YN, et al
    Risk Factors for Regrowth After Nonoperative Management for Rectal Cancer.
    Ann Surg Oncol. 2025;32:3098-3105.
    PubMed     Abstract available
    
    
    
30. NG JC, Sileo A, Sassun R, Aboelmaaty S, et al
    Predictors of Pathologic Non-response to Neoadjuvant Approaches in Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2025;32:3089-3097.
    PubMed     Abstract available
    
    
    
31. LI ZF, Zhang JN, Tian S, Sun C, et al
    Dual-Time-Point Radiomics for Prognosis Prediction in Colorectal Liver Metastasis Treated with Neoadjuvant Therapy Before Radical Resection: A Two-Center Study.
    Ann Surg Oncol. 2025;32:3516-3525.
    PubMed     Abstract available
    
    
    
32. KAWASHIMA J, Akabane M, Endo Y, Woldesenbet S, et al
    A Composite Endpoint of Liver Surgery (CELS): Development and Validation of a Clinically Relevant Endpoint Requiring a Smaller Sample Size.
    Ann Surg Oncol. 2025;32:3505-3515.
    PubMed     Abstract available
    
    
    
33. GREENSPUN BC, Metzger DA, Foshag A, Marshall TE, et al
    Impact of Delayed Surgery on Local Colorectal Neuroendocrine Tumors: Is Surveillance a Feasible Option?
    Ann Surg Oncol. 2025;32:3112-3118.
    PubMed     Abstract available
    
    
    
34. SCHLEIMER LE, Liu A, Kalvin HL, Barekzai AB, et al
    Robotic Versus Open Placement of Hepatic Artery Infusion Pumps.
    Ann Surg Oncol. 2025;32:3488-3498.
    PubMed     Abstract available
    
    
    
35. ENBLAD M, Cashin P, Ghanipour L, Graf W, et al
    Patterns of Preoperative Tumor Markers Can Predict Resectability and Prognosis of Peritoneal Metastases: A Clustering Analysis.
    Ann Surg Oncol. 2025;32:3638-3647.
    PubMed     Abstract available
    
    
    
36. ZHAN Z, Chen B, Lin W, Chen X, et al
    Rising Burden of Colon and Rectum Cancer in China: An Analysis of Trends, Gender Disparities, and Projections to 2030.
    Ann Surg Oncol. 2025;32:3361-3371.
    PubMed     Abstract available
    
    
    
37. EIKENBOOM EL, Nasar N, Seier K, Gonen M, et al
    Survival of Patients with Resected Microsatellite Instability-High, Mismatch Repair Deficient, and Lynch Syndrome-Associated Pancreatic Ductal Adenocarcinomas.
    Ann Surg Oncol. 2025;32:3568-3577.
    PubMed     Abstract available
    
    
    April 2025
38. TAQI K, Mack L, Bouchard-Fortier A
    ASO Authors Reflections: Beyond the Boundaries of Colorectal Cancer Peritoneal and Liver Metastases: Insights from a Systematic Review.
    Ann Surg Oncol. 2025 Apr 29. doi: 10.1245/s10434-025-17395.
    PubMed    
    
    
    
39. LOEHRER AP, Wang Q, O'Malley AJ, Wong SL, et al
    Influence of Medicaid Expansion on Rural Medicare Beneficiaries Undergoing Colon Cancer-Directed Surgery in the United States.
    Ann Surg Oncol. 2025 Apr 4. doi: 10.1245/s10434-025-17266.
    PubMed     Abstract available
    
    
    
40. MANGIERI CW, Votanopoulos KI, Shen P, Levine EA, et al
    Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, is it Appropriate?
    Ann Surg Oncol. 2025;32:2893-2902.
    PubMed     Abstract available
    
    
    
41. WALE A, Harris H, Brown G
    Diagnostic Certainty in Characterizing Liver Lesions in Rectal Cancer: Abbreviated Liver MRI versus CT.
    Ann Surg Oncol. 2025;32:2435-2445.
    PubMed     Abstract available
    
    
    
42. MAKI H, Ayabe RI, Haddad A, Nishioka Y, et al
    Associations of KRAS Point Mutations with Survival of Patients Who Underwent Curative-Intent Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2025;32:2425-2434.
    PubMed     Abstract available
    
    
    
43. SILEO A, Sassun R, Ng JC, Aboelmaaty S, et al
    Age Matters: Early-Onset Rectal Cancer Exhibits Higher Rates of Pathological Complete Response: A Retrospective Analysis of the Influence of Young Age on Treatment Success in Stage II-III Rectal Cancer.
    Ann Surg Oncol. 2025;32:2302-2307.
    PubMed     Abstract available
    
    
    
44. WANG A, Zhang P, Zang J, Zhang X, et al
    Total Pelvic Exenteration with Presacral Fascia and Pelvic Musculature Excision for Pelvic Recurrence of Rectal Cancer.
    Ann Surg Oncol. 2025;32:2308-2309.
    PubMed     Abstract available
    
    
    
45. COUBEAU L, Foguenne M, Marique L, Bonaccorsi Riani E, et al
    RAPID-Type Auxiliary Liver Transplantation for Unresectable Colorectal Liver Metastases: A First-Stage Surgical Video.
    Ann Surg Oncol. 2025;32:2300-2301.
    PubMed     Abstract available
    
    
    
46. FALLON EA, Awiwi MO, Bhutiani N, Helmink B, et al
    Peritoneal Cancer Index Correlates with Radiographic Assessment of Colorectal Carcinomatosis.
    Ann Surg Oncol. 2025;32:2923-2931.
    PubMed     Abstract available
    
    
    
47. GAN Y, Hu Q, Shen Q, Lin P, et al
    Comparison of Intratumoral and Peritumoral Deep Learning, Radiomics, and Fusion Models for Predicting KRAS Gene Mutations in Rectal Cancer Based on Endorectal Ultrasound Imaging.
    Ann Surg Oncol. 2025;32:3019-3030.
    PubMed     Abstract available
    
    
    
48. TROESTER A, Weaver L, Mott SL, Welton L, et al
    Patterns of Care and Oncologic Outcomes after Pelvic Exenteration for Locally Advanced Rectal Cancer in the United States.
    Ann Surg Oncol. 2025;32:2271-2281.
    PubMed     Abstract available
    
    
    
49. MOYA-MENDEZ ME, Schaps D, Penvose KN, Chang D, et al
    Weekly Patient-Reported Venous Thromboembolism Prophylaxis Adherence After Colorectal Cancer Surgery.
    Ann Surg Oncol. 2025 Apr 1. doi: 10.1245/s10434-025-17267.
    PubMed    
    
    
    March 2025
50. METZGER DA, Greenspun BC, Brouwer J, Li Y, et al
    ASO Visual Abstract: Genomic Signatures of Recurrence After Resection of Early-Stage Node-Negative Colon Cancer.
    Ann Surg Oncol. 2025 Mar 24. doi: 10.1245/s10434-025-17163.
    PubMed    
    
    
    
51. ENGLUM BR, Sahoo S, Mayorga-Carlin M, Siddiqui T, et al
    Disparities in Colorectal Cancer Screening and Diagnoses in the COVID Era: A Study of the VA Health System.
    Ann Surg Oncol. 2025 Mar 20. doi: 10.1245/s10434-025-17153.
    PubMed     Abstract available
    
    
    
52. HANEVELT J, Brohet RM, Moons LMG, Lacle MM, et al
    ASO Visual Abstract: Risk of Lymph Node Metastasis in T2 Colon Cancer: A Nationwide Population-Based Cohort Study.
    Ann Surg Oncol. 2025 Mar 3. doi: 10.1245/s10434-025-17071.
    PubMed    
    
    
    
53. KENARY PY, Ross S, Sucandy I
    Robotic Subtotal Caudate Lobe Hepatic Resection for Paracaval Colorectal Metastasis: Technique of Inferior Vena Cava Dissection and Handling.
    Ann Surg Oncol. 2025;32:1769-1770.
    PubMed     Abstract available
    
    
    
54. HADDAD A, Khavandi MM, Lendoire M, Acidi B, et al
    Propensity Score-Matched Analysis of Liver Venous Deprivation and Portal Vein Embolization Before Planned Hepatectomy in Patients with Extensive Colorectal Liver Metastases and High-Risk Factors for Inadequate Regeneration.
    Ann Surg Oncol. 2025;32:1752-1761.
    PubMed     Abstract available
    
    
    
55. KOBAYASHI K, Inoue Y, Oba A, Ono Y, et al
    Strategies for Recurrent Colorectal Liver Metastases Based on Prognostic Factors and Resectability: Potential Benefit of Multidisciplinary Treatment.
    Ann Surg Oncol. 2025;32:1729-1741.
    PubMed     Abstract available
    
    
    February 2025
56. METZGER D, Greenspun B, Siolas D, Jafari M, et al
    ASO Author Reflections: Risk Stratification Using Genomic Data for Early-Stage Colon Cancer.
    Ann Surg Oncol. 2025 Feb 26. doi: 10.1245/s10434-025-17089.
    PubMed    
    
    
    
57. SAMMOUR T
    Invited Editorial: "Role of Adjuvant Chemotherapy After Surgical Resection of Paraaortic Lymph Node Metastasis from Colorectal Cancer-A Multicenter Retrospective Study," by Nozawa et al.
    Ann Surg Oncol. 2025 Feb 26. doi: 10.1245/s10434-025-17044.
    PubMed    
    
    
    
58. DHIMAL T, Fleming FJ
    Neoadjuvant Immunotherapy in Operable Colon Cancer: Opportunities and Challenges.
    Ann Surg Oncol. 2025 Feb 23. doi: 10.1245/s10434-025-17043.
    PubMed    
    
    
    
59. METZGER DA, Greenspun BC, Brouwer J, Li Y, et al
    Genomic Signatures of Recurrence After Resection of Early-Stage Node-Negative Colon Cancer.
    Ann Surg Oncol. 2025 Feb 13. doi: 10.1245/s10434-025-17014.
    PubMed     Abstract available
    
    
    
60. HANEVELT J, Brohet RM, Moons LMG, Lacle MM, et al
    ASO Author Reflections: Pushing the Boundaries of Local Excision: How Does the Risk of Lymph Node Metastases Compare to Those Associated with Major Surgery in T2 Colon Cancer Patients?
    Ann Surg Oncol. 2025 Feb 13. doi: 10.1245/s10434-025-16997.
    PubMed    
    
    
    
61. MI SY, Liao YJ, Kang D, Tang X, et al
    Decreasing Use of CT in Favor of Colonoscopy: A Retrospective Analysis of Post-Operative Imaging in Nonmetastatic dMMR/MSI-H Sporadic Colorectal Cancer.
    Ann Surg Oncol. 2025 Feb 13. doi: 10.1245/s10434-025-16989.
    PubMed     Abstract available
    
    
    
62. SCHLEIMER LE, Hakki L, Seier K, Seo SK, et al
    Surgical Site Infections in Simultaneous Colorectal and Liver Resections for Metastatic Colorectal Adenocarcinoma.
    Ann Surg Oncol. 2025;32:1043-1053.
    PubMed     Abstract available
    
    
    
63. LIU A, Lowe M, Niedzwiecki D, Rhodin KE, et al
    Perioperative and Oncologic Outcomes of Hepatic Arterial Infusion (HAI) Pump Chemotherapy for Patients with Unresectable Colorectal Liver Metastases at an Expanding HAI Program.
    Ann Surg Oncol. 2025;32:1033-1042.
    PubMed     Abstract available
    
    
    
64. LIMA DE ARAUJO CA, de Freitas Busnardo F, Thome Grillo VA, Chirnev Felicio CH, et al
    Effect of Early Postoperative Mobilization on Functional Recovery, Hospital Length of Stay, and Postoperative Complications After Immediate Internal Pudendal Artery Perforator Flap Reconstruction for Irradiated Abdominoperineal Resection Defects: A Pr
    Ann Surg Oncol. 2025;32:993-1004.
    PubMed     Abstract available
    
    
    
65. LIU LL, Lin YK, Xiang ZL
    The Value of Primary Tumor Resection in Patients with Liver Metastases: A 10-Year Outcome.
    Ann Surg Oncol. 2025;32:1083-1092.
    PubMed     Abstract available
    
    
    
66. WINICKI NM, Radomski SN, Florissi IS, Wethington S, et al
    Management of the Uninvolved Uterus and Adnexa During Routine Pelvic Peritonectomy in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Varies by Histology and Menopausal Status: An International Survey of Peritoneal Surface Malignan
    Ann Surg Oncol. 2025;32:671-678.
    PubMed     Abstract available
    
    
    January 2025
67. KANANI A, Veen T, Lea D, Zaharia C, et al
    ASO Visual Abstract: Neoadjuvant Immunotherapy Followed by Surgery Compared with Upfront Surgery Alone in Operable Colon Cancer with Deficient Mismatch Repair-Modelling Oncological Outcomes and Numbers Needed to Treat.
    Ann Surg Oncol. 2025 Jan 23. doi: 10.1245/s10434-025-16899.
    PubMed    
    
    
    
68. HANEVELT J, Brohet RM, Moons LMG, Lacle MM, et al
    Risk of Lymph Node Metastasis in T2 Colon Cancer: A Nationwide Population-Based Cohort Study.
    Ann Surg Oncol. 2025 Jan 23. doi: 10.1245/s10434-025-16921.
    PubMed     Abstract available
    
    
    
69. KANANI A, Veen T, Lea D, Zaharia C, et al
    Correction: Neoadjuvant Immunotherapy Followed by Surgery Compared with Upfront Surgery Alone in Operable Colon Cancer with Deficient Mismatch Repair: Modeling Oncological Outcomes and Numbers Needed to Treat.
    Ann Surg Oncol. 2025 Jan 9. doi: 10.1245/s10434-025-16888.
    PubMed    
    
    
    
70. TIDADINI F, Arvieux C, Glehen O, Sourrouille I, et al
    Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Using Open and Closed Abdomen Techniques for Colorectal Peritoneal Metastases and Peritoneal Pseudomyxoma Recurrences: Results from Six French Expert Centers.
    Ann Surg Oncol. 2025;32:209-220.
    PubMed     Abstract available
    
    
    
71. MATHEW J, Kazi M, Desouza A, Saklani A, et al
    Postoperative Morbidity and Factors Predicting the Development of Lymphoceles Following Lateral Pelvic Node Dissection for Rectal Cancer: A Cohort Study.
    Ann Surg Oncol. 2025;32:165-175.
    PubMed     Abstract available
    
    
    
72. FEFERMAN Y, Verheij FS, Williams H, Omer DM, et al
    Outcomes of Distal Rectal Cancer Patients Who Did Not Qualify for Watch-and-Wait: Comparison of Intersphincteric Resection Versus Abdominoperineal Resection.
    Ann Surg Oncol. 2025;32:128-136.
    PubMed     Abstract available
    
    
    
73. SASAKI K, Wang J, Kamphues C, Buettner S, et al
    Evaluating Combinations of Biological and Clinicopathologic Factors Linked to Poor Outcomes in Resected Colorectal Liver Metastasis: An External Validation Study.
    Ann Surg Oncol. 2025;32:408-417.
    PubMed     Abstract available
    
    
    
74. MURSHED I, Bunjo Z, Seow W, Murshed I, et al
    Economic Evaluation of 'Watch and Wait' Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review.
    Ann Surg Oncol. 2025;32:137-157.
    PubMed     Abstract available
    
    
    December 2024
75. SEDIGHIM S, Khorfan R, Shin J, Khan A, et al
    ASO Visual Abstract: Disparities in Palliative Treatment Utilization in Patients with Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2024 Dec 31. doi: 10.1245/s10434-024-16749.
    PubMed    
    
    
    
76. AREZO K, Torhild V, Dordi L, Claudia Z, et al
    Neoadjuvant Immunotherapy Followed by Surgery Compared with Upfront Surgery Alone in Operable Colon Cancer with Deficient Mismatch Repair: Modeling Oncological Outcomes and Numbers Needed to Treat.
    Ann Surg Oncol. 2024 Dec 30. doi: 10.1245/s10434-024-16755.
    PubMed     Abstract available
    
    
    
77. EL MOHEB M, Shen C, Kim S, Putman K, et al
    ASO Visual Abstract: Stage-Specific Tumoral Gene Expression Profiles of Black and White Patients with Colon Cancer.
    Ann Surg Oncol. 2024 Dec 30. doi: 10.1245/s10434-024-16695.
    PubMed    
    
    
    
78. QIN Y, Miyake T, Muramoto K, Maekawa T, et al
    ASO Visual Abstract: Fibroblast Activation Protein-alpha Expression in Cancer-Associated Fibroblasts Shows the Poor Survival of Colorectal Cancer via Immune-Mediated Pathways : Implications of FAP in Cancer-Associated Fibroblasts Link Immune Dysregula
    Ann Surg Oncol. 2024 Dec 30. doi: 10.1245/s10434-024-16750.
    PubMed    
    
    
    
79. ZHENG J, Wang T, Wang H, Yan B, et al
    ASO Visual Abstract: Use of a Pathomics Nomogram to Predict Postoperative Liver Metastasis in Patients with Stage III Colorectal Cancer.
    Ann Surg Oncol. 2024 Dec 26. doi: 10.1245/s10434-024-16680.
    PubMed    
    
    
    
80. MOHEB ME, Tsung A
    ASO Author Reflections: Decoding Racial Differences in Colon Cancer Transcriptomes.
    Ann Surg Oncol. 2024 Dec 7. doi: 10.1245/s10434-024-16682.
    PubMed    
    
    
    
81. PATEL DD, Dickson PV
    Invited Editorial About: "Impact of Tumoral beta2-Adrenergic Receptor Expression on Chemotherapeutic Response and Prognosis in Patients with Advanced Colorectal Cancer," by C. Komine et al.
    Ann Surg Oncol. 2024 Dec 2. doi: 10.1245/s10434-024-16609.
    PubMed    
    
    
    
82. QIN Y, Miyake T, Muramoto K, Maekawa T, et al
    Fibroblast Activation Protein-alpha Expression in Cancer-Associated Fibroblasts Shows the Poor Survival of Colorectal Cancer via Immune-Mediated Pathways : Implications of FAP in Cancer-Associated Fibroblasts Link Immune Dysregulation to Adverse Survi
    Ann Surg Oncol. 2024 Dec 2. doi: 10.1245/s10434-024-16593.
    PubMed     Abstract available
    
    
    
83. KARAGKOUNIS G, Horvat N, Danilova S, Chhabra S, et al
    Computed Tomography-Based Radiomics with Machine Learning Outperforms Radiologist Assessment in Estimating Colorectal Liver Metastases Pathologic Response After Chemotherapy.
    Ann Surg Oncol. 2024;31:9196-9204.
    PubMed     Abstract available
    
    
    
84. RISBEY CWG, Brown KGM, Solomon M, McBride K, et al
    Cost Analysis of Pelvic Exenteration Surgery for Advanced Pelvic Malignancy.
    Ann Surg Oncol. 2024;31:9079-9087.
    PubMed     Abstract available
    
    
    
85. PALMIERI L, Santullo F, Lodoli C, Certelli C, et al
    Robotic Recto-Sigmoid Resection with Total Intracorporeal Colorectal Anastomosis (TICA) in Recurrent Ovarian Cancer.
    Ann Surg Oncol. 2024;31:8952-8953.
    PubMed     Abstract available
    
    
    
86. ALLIEVI N, Sidhom M, Samuel MV, Tzivanakis A, et al
    Survival Analysis and Recurrence Patterns in 555 Patients with Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2024;31:8585-8595.
    PubMed     Abstract available
    
    
    November 2024
87. ZHENG J, Wang T, Wang H, Yan B, et al
    Use of a Pathomics Nomogram to Predict Postoperative Liver Metastasis in Patients with Stage III Colorectal Cancer.
    Ann Surg Oncol. 2024 Nov 29. doi: 10.1245/s10434-024-16519.
    PubMed     Abstract available
    
    
    
88. LIU D, Chen Z, Deng W, Lan J, et al
    ASO Visual Abstract: An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer.
    Ann Surg Oncol. 2024 Nov 29. doi: 10.1245/s10434-024-16599.
    PubMed    
    
    
    
89. LIU D, Chen Z, Deng W, Lan J, et al
    An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer.
    Ann Surg Oncol. 2024 Nov 26. doi: 10.1245/s10434-024-16469.
    PubMed     Abstract available
    
    
    
90. EL MOHEB M, Shen C, Kim S, Putman K, et al
    Stage-Specific Tumoral Gene Expression Profiles of Black and White Patients with Colon Cancer.
    Ann Surg Oncol. 2024 Nov 23. doi: 10.1245/s10434-024-16550.
    PubMed     Abstract available
    
    
    
91. SEDIGHIM S, Khorfan R, Shin J, Khan A, et al
    Disparities in Palliative Treatment Utilization in Metastatic Colorectal Cancer Patients.
    Ann Surg Oncol. 2024 Nov 22. doi: 10.1245/s10434-024-16577.
    PubMed     Abstract available
    
    
    
92. KHORFAN R, Sedighim S, Caba-Molina D, Tran TB, et al
    National Trends and Outcomes in Cytoreductive Surgery for Colorectal Cancer with Peritoneal Metastases Before and After PRODIGE 7.
    Ann Surg Oncol. 2024 Nov 21. doi: 10.1245/s10434-024-16539.
    PubMed    
    
    
    
93. MEN V, Jin JZ
    ASO Author Reflections: Lymph Node Yield and Long-Term Survival in Colon Cancer-Insights from a 20-Year National Study.
    Ann Surg Oncol. 2024 Nov 20. doi: 10.1245/s10434-024-16565.
    PubMed    
    
    
    
94. LIU D, Yang K, Cai J
    ASO Author Reflections: Organoid Model to Aid the Decision of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer.
    Ann Surg Oncol. 2024 Nov 20. doi: 10.1245/s10434-024-16555.
    PubMed    
    
    
    
95. ZHENG J, Wang T, Wang S, Ji H, et al
    ASO Author Reflections: Use of a Pathomics Nomogram to Predict Postoperative Liver Metastasis in Patients with Stage III Colorectal Cancer.
    Ann Surg Oncol. 2024 Nov 20. doi: 10.1245/s10434-024-16576.
    PubMed    
    
    
    
96. MEN V, Bahl P, Jin JZ, Singh PP, et al
    ASO Visual Abstract: Lymph Node Yield and Long-Term Mortality Risk in Patients with Colon Cancer: A 20-Year Follow-Up National Study.
    Ann Surg Oncol. 2024 Nov 19. doi: 10.1245/s10434-024-16513.
    PubMed    
    
    
    
97. NOZAWA H, Ito S, Sasaki K, Murono K, et al
    Role of Adjuvant Chemotherapy After Surgical Resection of Paraaortic Lymph Node Metastasis from Colorectal Cancer-A Multicenter Retrospective Study.
    Ann Surg Oncol. 2024 Nov 18. doi: 10.1245/s10434-024-16537.
    PubMed     Abstract available
    
    
    
98. HADDAD A, Lendoire M, Uppal A, Maki H, et al
    CEA Rebound After Discontinuation of Pre-Hepatectomy Chemotherapy Predicts Worse Outcomes After Resection of Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2024 Nov 8. doi: 10.1245/s10434-024-16370.
    PubMed     Abstract available
    
    
    
99. ALTAF A, Woldesenbet S, Munir MM, Khan MMM, et al
    ASO Visual Abstract: Clinical Outcomes, Costs, and Value of Undergoing Surgery Among Older Patients with Colon Cancer at U.S. News & World Report Ranked Versus Unranked Hospitals.
    Ann Surg Oncol. 2024 Nov 6. doi: 10.1245/s10434-024-16406.
    PubMed    
    
    
    
100. MEN V, Bahl P, Jin JZ, Singh PP, et al
     Lymph Node Yield and Long-Term Mortality Risk in Patients with Colon Cancer: A 20-Year Follow-Up National Study.
     Ann Surg Oncol. 2024 Nov 4. doi: 10.1245/s10434-024-16428.
     PubMed     Abstract available
     
     
     
101. ZHANG H, Zhuo C, Lin R, Ke F, et al
     ASO Author Reflections: Why are the Identification and Verification of Key Genes in Colorectal Cancer Liver Metastases so Important?
     Ann Surg Oncol. 2024 Nov 4. doi: 10.1245/s10434-024-16334.
     PubMed    
     
     
     
102. WAHEED MT, Ruel N, Whelan RL, Fakih M, et al
     Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial.
     Ann Surg Oncol. 2024;31:7998-8007.
     PubMed     Abstract available
     
     
     
103. KAWADA K, Inamura Y, Morikawa A, Matsuoka H, et al
     Perineal-First Approach in Robotic Abdominoperineal Resection.
     Ann Surg Oncol. 2024;31:7820-7821.
     PubMed     Abstract available
     
     
     
104. WANG A, Wang A, Xu X, Chen M, et al
     ASO Author Reflections: Simultaneous Robotic Surgery for Rectal Gastrointestinal Stromal Tumor and Prostatic Cancer.
     Ann Surg Oncol. 2024;31:7852-7853.
     PubMed    
     
     
     
105. HILTY CHU BK, Loria A, Dhimal T, Cupertino P, et al
     ASO Author Reflections: Improving Shared-Decision Making in Rectal Cancer.
     Ann Surg Oncol. 2024;31:7856-7857.
     PubMed    
     
     
     
106. HILTY CHU BK, Loria A, Dhimal T, Li Y, et al
     The Rise of Patients Declining Rectal Cancer Surgery in the Era of Total Neoadjuvant Therapy.
     Ann Surg Oncol. 2024;31:7798-7806.
     PubMed     Abstract available
     
     
     
107. BROWN KGM, Solomon MJ
     Understanding Quality of Life After Pelvic Exenteration for Patients with Rectal Cancer.
     Ann Surg Oncol. 2024;31:7668-7670.
     PubMed    
     
     
     
108. WANG A, Wang A, Xu X, Chen M, et al
     Simultaneous Robotic Sphincter-Preserving Rectal Resection and Prostatectomy for Rectal Gastrointestinal Stromal Tumor and Prostatic Cancer.
     Ann Surg Oncol. 2024;31:7796-7797.
     PubMed     Abstract available
     
     
     October 2024
109. KIM SJ, Park MY, Yang SY, Han YD, et al
     ASO Visual Abstract: Minimally Invasive Surgery: Is It a Risk Factor for Postoperative Peritoneal Metastasis in pT4 Colon Cancer?
     Ann Surg Oncol. 2024 Oct 10. doi: 10.1245/s10434-024-16280.
     PubMed    
     
     
     
110. ZHANG H, Zhuo C, Lin R, Ke F, et al
     Identification and Verification of Key Genes in Colorectal Cancer Liver Metastases Through Analysis of Single-Cell Sequencing Data and TCGA Data.
     Ann Surg Oncol. 2024 Oct 9. doi: 10.1245/s10434-024-16194.
     PubMed     Abstract available
     
     
     
111. STEPHENS KR, Donica WRF, Egger ME, Philips P, et al
     Observed Changes in the Distribution of Colon Cancer Metastasis: A National Cancer Database Review and Institutional Experience.
     Ann Surg Oncol. 2024 Oct 8. doi: 10.1245/s10434-024-16330.
     PubMed     Abstract available
     
     
     
112. DOSSA F, Weiser MR
     Omission of Radiotherapy for Locally Advanced Rectal Cancer: A Step Toward Patient-Centric Treatment Decision-Making.
     Ann Surg Oncol. 2024;31:6337-6341.
     PubMed    
     
     
     
113. WEAVER L, Goffredo P
     ASO Author Reflections: Malignant Colon Polyps-Is Tumor Laterality the New Black?
     Ann Surg Oncol. 2024;31:6472-6473.
     PubMed    
     
     
     
114. WEAVER L, Boatman S, Kohn J, Mott SL, et al
     The Role of Tumor Location on Endoscopic and Surgical Management of Malignant Colon Polyps.
     Ann Surg Oncol. 2024;31:6452-6460.
     PubMed     Abstract available
     
     
     
115. JEONG MH, Kang SJ, Park SY, Kwak SG, et al
     Comparison of EPIC Versus HIPEC in the Treatment of Colorectal Peritoneal Metastases and Appendix Tumors Using Inverse Probability of Treatment Weighting.
     Ann Surg Oncol. 2024;31:7111-7121.
     PubMed     Abstract available
     
     
     
116. SCHWANTES IR, Patel RK, Kardosh A, Paxton J, et al
     A Modified Floxuridine Reduced-Dose Protocol for Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion.
     Ann Surg Oncol. 2024;31:6537-6545.
     PubMed     Abstract available
     
     
     
117. GLYNNE-JONES R
     Editorial: "Pathologic Complete Response, Total Neoadjuvant Therapy, and the Survival Paradox in Locally Advanced Rectal Cancer," by Goffredo et al. Without Constancy There is Neither Love, Friendship, Nor Virtue in the World.
     Ann Surg Oncol. 2024;31:6344-6347.
     PubMed    
     
     
     
118. GOFFREDO P, Suraju MO, Mott SL, Troester AM, et al
     Pathologic Complete Response, Total Neoadjuvant Therapy and the Survival Paradox in Locally Advanced Rectal Cancer.
     Ann Surg Oncol. 2024;31:6432-6442.
     PubMed     Abstract available
     
     
     
119. TROESTER A, Hassan I, Goffredo P
     ASO Author Reflections: Not All pCRs are Created Equal in Rectal Cancer.
     Ann Surg Oncol. 2024;31:6470-6471.
     PubMed    
     
     
     
120. WILLIAMS H, Thompson HM, Lee C, Rangnekar A, et al
     Assessing Endoscopic Response in Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy: Development and Validation of a Highly Accurate Convolutional Neural Network.
     Ann Surg Oncol. 2024;31:6443-6451.
     PubMed     Abstract available
     
     
     September 2024
121. KOMINE C, Sohda M, Yokobori T, Shioi I, et al
     Impact of Tumoral beta2-Adrenergic Receptor Expression on Chemotherapeutic Response and Prognosis in Patients with Advanced Colorectal Cancer.
     Ann Surg Oncol. 2024 Sep 28. doi: 10.1245/s10434-024-16195.
     PubMed     Abstract available
     
     
     
122. KOMINE C, Sohda M, Yokobori T, Shioi I, et al
     ASO Visual Abstract: Impact of Tumoral beta2-Adrenergic Receptor Expression on Chemotherapeutic Response and Prognosis in Patients with Advanced Colorectal Cancer.
     Ann Surg Oncol. 2024 Sep 27. doi: 10.1245/s10434-024-16285.
     PubMed    
     
     
     
123. KOBAYASHI K, Toritani K, Kimura H, Kawashima J, et al
     ASO Visual Abstract: Differences in Prognosis and Recurrence Patterns Between Ulcerative Colitis-Associated Colorectal Cancer and Sporadic Colorectal Cancer-A Matched Pair Analysis.
     Ann Surg Oncol. 2024 Sep 26. doi: 10.1245/s10434-024-16271.
     PubMed    
     
     
     
124. ALTAF A, Pawlik TM
     ASO Author Reflections: Clinical Outcomes, Costs, and Value of Undergoing Surgery among Older Patients with Colon Cancer at U.S. News & World Report Ranked versus Unranked Hospitals.
     Ann Surg Oncol. 2024 Sep 23. doi: 10.1245/s10434-024-16274.
     PubMed    
     
     
     
125. KIM SJ, Park MY, Yang SY, Han YD, et al
     Minimally Invasive Surgery: Is It a Risk Factor for Postoperative Peritoneal Metastasis in pT4 Colon Cancer?
     Ann Surg Oncol. 2024 Sep 16. doi: 10.1245/s10434-024-16177.
     PubMed     Abstract available
     
     
     
126. ALTAF A, Woldesenbet S, Munir MM, Khan MMM, et al
     Clinical Outcomes, Costs, and Value of Surgery Among Older Patients with Colon Cancer at US News and World Report Ranked Versus Unranked Hospitals.
     Ann Surg Oncol. 2024 Sep 14. doi: 10.1245/s10434-024-16217.
     PubMed     Abstract available
     
     
     
127. KOBAYASHI K, Toritani K, Kimura H, Kawashima J, et al
     Differences in Prognosis and Recurrence Patterns Between Ulcerative Colitis-Associated Colorectal Cancer and Sporadic Colorectal Cancer: A Matched-Pair Analysis.
     Ann Surg Oncol. 2024 Sep 7. doi: 10.1245/s10434-024-16158.
     PubMed     Abstract available
     
     
     
128. YU AT, Hanna DN, Li TM, Sarfaty E, et al
     Genetic Clustering of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Patients of Colorectal Origin: KRAS and Not TP53 Cluster Alterations are Associated with Poor Outcomes.
     Ann Surg Oncol. 2024;31:6252-6261.
     PubMed     Abstract available
     
     
     
129. LEITAO MM JR, Weiser MR, Mueller JJ
     Uterine Anastomosis with Low Anterior Resection.
     Ann Surg Oncol. 2024;31:6048.
     PubMed     Abstract available
     
     
     
130. GOFFREDO P, Suraju MO, Mott SL, Troester AM, et al
     ASO Visual Abstract: Pathologic Complete Response, Total Neoadjuvant Therapy, and the Survival Paradox in Locally Advanced Rectal Cancer.
     Ann Surg Oncol. 2024;31:5971-5972.
     PubMed    
     
     
     
131. DOROUDIAN S, Osterman E, Glimelius B
     Risk Factors for Recurrence After Surgery for Rectal Cancer in a Modern, Nationwide Population-Based Cohort.
     Ann Surg Oncol. 2024;31:5570-5584.
     PubMed     Abstract available
     
     
     
132. SADAMORI H, Monden K, Hioki M, Iwasaki H, et al
     Liver Resection Under Total Hepatic Vascular Exclusion with In Situ Hypothermic Isolated Hepatic Perfusion for Advanced Liver Tumors.
     Ann Surg Oncol. 2024;31:5638-5639.
     PubMed     Abstract available
     
     
     
133. NOIRET B, Piessen G, Eveno C
     ASO Author Reflections: Centralization of Cytoreductive Surgery Alone in Colorectal Peritoneal Metastases Patients: Optimizing Treatment Pathways.
     Ann Surg Oncol. 2024;31:6274-6275.
     PubMed    
     
     
     
134. NOIRET B, Lenne X, Bruandet A, Piessen G, et al
     Should Cytoreductive Surgery Alone for Peritoneal Metastases of Colorectal Origin be Centralized? A National Study of 4159 Procedures.
     Ann Surg Oncol. 2024;31:6220-6227.
     PubMed     Abstract available
     
     
     August 2024
135. CO LMB, Dychiao RGK, Capistrano MPR, Tayag MT, et al
     Identifying Gaps in Early-Onset Colorectal Cancer Prevention, Screening, and Treatment in the Philippines.
     Ann Surg Oncol. 2024 Aug 22. doi: 10.1245/s10434-024-16038.
     PubMed    
     
     
     
136. EMILE SH, Horesh N, Garoufalia Z, Dourado J, et al
     ASO Visual Abstract: Accuracy of Clinical Staging of Localized Colon Cancer-A National Cancer Database Cohort Analysis.
     Ann Surg Oncol. 2024 Aug 21. doi: 10.1245/s10434-024-16101.
     PubMed    
     
     
     
137. REITZ ACW, Massarweh NN
     Preoperative Staging of Colon Cancer-Picking the Lesser of Two Evils.
     Ann Surg Oncol. 2024 Aug 16. doi: 10.1245/s10434-024-16052.
     PubMed    
     
     
     
138. CHEN M, Deng S, Cao Y, Wang J, et al
     ASO Visual Abstract: Mitochondrial DNA Copy Number as a Biomarker for Guiding Adjuvant Chemotherapy in Stages II and III Colorectal Cancer Patients with Mismatch Repair Deficiency: Seeking Benefits and Avoiding Harms.
     Ann Surg Oncol. 2024 Aug 8. doi: 10.1245/s10434-024-15989.
     PubMed    
     
     
     
139. STEFFENS D, Nott F, Koh C, Jiang W, et al
     ASO Visual Abstract: Effectiveness of Prehabilitation Modalities on Postoperative Outcomes Following Colorectal Cancer Surgery: A Systematic Review of Randomised Controlled Trials.
     Ann Surg Oncol. 2024 Aug 5. doi: 10.1245/s10434-024-15978.
     PubMed    
     
     
     
140. WILLIAMS H, Thompson HM, Lee C, Rangnekar A, et al
     ASO Visual Abstract: Assessing Endoscopic Response in Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy: Development and Validation of a Highly Accurate Convolutional Neural Network.
     Ann Surg Oncol. 2024;31:5002-5003.
     PubMed    
     
     
     
141. NABATA KJ, Rai S, Zhao D, MacNeill AJ, et al
     ASO Visual Abstract: Negative Pressure Wound Therapy to Reduce Surgical Site Infections After CRS/HIPEC.
     Ann Surg Oncol. 2024;31:5219.
     PubMed    
     
     
     
142. CIFTCI Y, Radomski SN, Johnston FM, Greer JB, et al
     ASO Author Reflections: One Size Does Not Fit All-Enhanced Recovery After Surgery in CRS-HIPEC.
     Ann Surg Oncol. 2024;31:5400-5401.
     PubMed    
     
     
     
143. LAROCHE S, Scatton O, Charlotte F, Bachet JB, et al
     ASO Visual Abstract: Prognosis of a Heterogeneous TRG Pathological Response to Neoadjuvant Chemotherapy in Patients Who Undergo Resection for Colorectal Liver Metastases.
     Ann Surg Oncol. 2024;31:5217-5218.
     PubMed    
     
     
     July 2024
144. EMILE SH, Wexner SD
     ASO Author Reflections: Clinical Staging of Localized Colon Cancer: Room for Improvement.
     Ann Surg Oncol. 2024 Jul 29. doi: 10.1245/s10434-024-15956.
     PubMed    
     
     
     
145. EMILE SH, Horesh N, Garoufalia Z, Dourado J, et al
     Accuracy of Clinical Staging of Localized Colon Cancer: A National Cancer Database Cohort Analysis.
     Ann Surg Oncol. 2024 Jul 29. doi: 10.1245/s10434-024-15875.
     PubMed     Abstract available
     
     
     
146. CHEN M, Deng S, Cao Y, Huang L, et al
     ASO Author Reflections: Stage II/III Colorectal Cancer Patients with Mismatch Repair Deficiency Need More Personalized Adjuvant Chemotherapy.
     Ann Surg Oncol. 2024 Jul 29. doi: 10.1245/s10434-024-15926.
     PubMed    
     
     
     
147. NEE K, Hosohama L, Alobuia W, Kim AC, et al
     Defining Colorectal Cancer Cells on a Single Cell Level Reveals LGR5+ Proliferative Stem Cell Expression in Peritoneal Metastasis.
     Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15783.
     PubMed    
     
     
     
148. ROXBURGH CS
     Time to Change Strategy in Non-metastatic Locally Advanced Mismatch Repair-Deficient Colon Cancer.
     Ann Surg Oncol. 2024 Jul 11. doi: 10.1245/s10434-024-15780.
     PubMed    
     
     
     
149. STEFFENS D, Solomon MJ, Jack S, West MA, et al
     ASO Author Reflections: Improving Postoperative Outcomes in Colorectal Cancer Surgery: Where are We with Prehabilitation?
     Ann Surg Oncol. 2024 Jul 11. doi: 10.1245/s10434-024-15835.
     PubMed    
     
     
     
150. SMITH HG, Schlesinger NH, Chiranth D, Qvortrup C, et al
     ASO Visual Abstract: The Association of Mismatch Repair Status with Microscopically Positive (R1) Margins in Stage III Colorectal Cancer-A Retrospective Cohort Study.
     Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15747.
     PubMed    
     
     
     
151. CHEN M, Deng S, Cao Y, Wang J, et al
     Mitochondrial DNA Copy Number as a Biomarker for Guiding Adjuvant Chemotherapy in Stages II and III Colorectal Cancer Patients with Mismatch Repair Deficiency: Seeking Benefits and Avoiding Harms.
     Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15759.
     PubMed     Abstract available
     
     
     
152. LIN X, Haiyang Z
     Patient-Reported Outcomes in Chinese Patients with Locally Advanced or Recurrent Colorectal Cancer After Pelvic Exenteration.
     Ann Surg Oncol. 2024 Jul 9. doi: 10.1245/s10434-024-15722.
     PubMed     Abstract available
     
     
     
153. LIN X, Haiyang Z
     ASO Author Reflections: Pelvic Exenteration for Chinese Patients with Locally Advanced or Recurrent Colorectal Cancer: A Report of 122 Cases.
     Ann Surg Oncol. 2024 Jul 8. doi: 10.1245/s10434-024-15782.
     PubMed    
     
     
     
154. AYABE RI, Beaty K, Newhook TE, Cao HST, et al
     Incomplete Cytoreduction and Need for Major Hepatectomy Predict Shorter Survival in Patients Undergoing Combined Cytoreductive Surgery and Hepatectomy for Metastatic Colorectal Cancer.
     Ann Surg Oncol. 2024 Jul 6. doi: 10.1245/s10434-024-15694.
     PubMed    
     
     
     
155. JANCZEWSKI LM, Asare EA, Goodman KA
     Updates on the Version 9 American Joint Committee on Cancer Staging System for Anal Cancer.
     Ann Surg Oncol. 2024;31:4155-4158.
     PubMed    
     
     
     
156. SUGUMAR K, Stitzel H, Wu V, Bajor D, et al
     ASO Visual Abstract: Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
     Ann Surg Oncol. 2024;31:4466-4467.
     PubMed    
     
     
     
157. VAN DER VEN RGFM, van den Heuvel TBM, Rovers KPB, Nienhuijs SW, et al
     ASO Visual Abstract: Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases-A Nationwide Population-Based Study.
     Ann Surg Oncol. 2024;31:4749-4750.
     PubMed    
     
     
     
158. SHAPERA E, Ross S, Pattilachan T, Christodoulou M, et al
     Robotic Biliary Stricturoplasty and Roux-en-Y Hepaticojejunostomy After Hepatic Artery Infusion Pump Injury.
     Ann Surg Oncol. 2024;31:4449-4451.
     PubMed     Abstract available
     
     
     
159. LAROCHE S, Scatton O, Charlotte F, Bachet JB, et al
     Prognosis of a Heterogeneous TRG Pathological Response to Neoadjuvant Chemotherapy in Patients who Undergo Resection for Colorectal Liver Metastases.
     Ann Surg Oncol. 2024;31:4436-4444.
     PubMed     Abstract available
     
     
     
160. EL ASMAR A, Kamdem L, Khaled C, Liberale G, et al
     ASO Author Reflections: Histological Growth Patterns of Colorectal Peritoneal Metastases Significantly Affect Prognosis in Patients Presenting for Curative-Intent Cytoreductive Surgery.
     Ann Surg Oncol. 2024;31:4558-4559.
     PubMed    
     
     
     
161. BLANCO ASENSIO N, Aliseda Jover D, Marti-Cruchaga P, Lapuente F, et al
     Anatomical Left Hepatectomy Extended to Caudate Lobe due to Colorectal Metastasis with Intrabiliary Growth: Securing Optimal Margins with a Laennec's Capsule Approach and Vein-Guided Resection.
     Ann Surg Oncol. 2024;31:4447-4448.
     PubMed    
     
     
     
162. SANKARAN R, O'Connor J, Nuliyalu U, Diaz A, et al
     Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers.
     Ann Surg Oncol. 2024;31:4339-4348.
     PubMed     Abstract available
     
     
     
163. SUGUMAR K, Stitzel H, Wu V, Bajor D, et al
     Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
     Ann Surg Oncol. 2024;31:4413-4426.
     PubMed     Abstract available
     
     
     June 2024
164. BHUTIANI N, Ochiai K, Awiwi MO, Rodriguez-Bigas MA, et al
     ASO Visual Abstract: Para-aortic Lymph Node Dissection for Colorectal Cancer-Predicting Pathologic Lymph Node Positivity and Optimizing Outcomes.
     Ann Surg Oncol. 2024 Jun 29. doi: 10.1245/s10434-024-15690.
     PubMed    
     
     
     
165. STEFFENS D, Nott F, Koh C, Jiang W, et al
     Effectiveness of Prehabilitation Modalities on Postoperative Outcomes Following Colorectal Cancer Surgery: A Systematic Review of Randomised Controlled Trials.
     Ann Surg Oncol. 2024 Jun 24. doi: 10.1245/s10434-024-15593.
     PubMed     Abstract available
     
     
     
166. SMITH HG, Schlesinger NH, Chiranth D, Qvortrup C, et al
     The Association of Mismatch Repair Status with Microscopically Positive (R1) Margins in Stage III Colorectal Cancer: A Retrospective Cohort Study.
     Ann Surg Oncol. 2024 Jun 21. doi: 10.1245/s10434-024-15595.
     PubMed     Abstract available
     
     
     
167. BHUTIANI N, Ochiai K, Awiwi MO, Rodriguez-Bigas MA, et al
     Para-aortic Lymph Node Dissection for Colorectal Cancer: Predicting Pathologic Lymph Node Positivity and Optimizing Outcomes.
     Ann Surg Oncol. 2024 Jun 5. doi: 10.1245/s10434-024-15539.
     PubMed     Abstract available
     
     
     
168. SHIN JK, Kim HC
     ASO Author Reflections: Robotic Surgery is Beneficial for Rectal Cancer Patients with Unfavorable Characteristic After Neoadjuvant Chemoradiotherapy.
     Ann Surg Oncol. 2024;31:3959-3960.
     PubMed    
     
     
     
169. VAN DER VEN RGFM, van den Heuvel TBM, Rovers KPB, Nienhuijs SW, et al
     ASO Author Reflections: Addressing Hospital-Based Disparities in Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) and Survival in Patients with Isolated Colorectal Peritoneal Metastases.
     Ann Surg Oncol. 2024;31:3787-3788.
     PubMed    
     
     
     
170. KAMDEM L, Asmar AE, Demetter P, Zana IC, et al
     Retrospective Evaluation of the Prognostic Value of Histological Growth Pattern in Patients with Colorectal Peritoneal Metastases Undergoing Curative-Intent Cytoreductive Surgery.
     Ann Surg Oncol. 2024;31:3778-3784.
     PubMed     Abstract available
     
     
     
171. VAN DER VEN RGFM, van den Heuvel TBM, Rovers KPB, Nienhuijs SW, et al
     Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases: A Nationwide Population-Based Study.
     Ann Surg Oncol. 2024;31:3758-3768.
     PubMed     Abstract available
     
     
     
172. PIKOULIS E, Beyer K, Kreis ME, Pawlik TM, et al
     ASO Author Reflections: Surgical Technique for Colorectal Liver Metastases: Biology is King, but the Princes and Princesses (Surgical Techniques) also Matter.
     Ann Surg Oncol. 2024;31:4046-4047.
     PubMed    
     
     
     May 2024
173. HUANG Y, Liao F, Chen H, Shu X, et al
     ASO Author Reflections: Self-expanding Metal Stents for Right-Sided Colonic Cancer Obstruction.
     Ann Surg Oncol. 2024;31:3242-3243.
     PubMed    
     
     
     
174. GOMAA I, Aboelmaaty S, Narasimhan AL, Bhatt H, et al
     The Impact of Enhanced Recovery on Long-Term Survival in Rectal Cancer.
     Ann Surg Oncol. 2024;31:3233-3241.
     PubMed     Abstract available
     
     
     
175. ONO Y, Inoue Y, Ito H, Takahashi Y, et al
     ASO Author Reflections: Advancing Two-Stage Hepatectomy: Laparoscopic Portal Vein Ligation and Embolization for Initially Unresectable Colorectal Liver Metastases.
     Ann Surg Oncol. 2024;31:3114-3115.
     PubMed    
     
     
     
176. HUANG Y, Liao F, Zhan Z, Chen X, et al
     Efficacy and Safety Analysis of Emergency Endoscopic Self-Expanding Metal Stent Placement Without Fluoroscopic Assistance for Right-Sided Colonic Cancer Obstruction.
     Ann Surg Oncol. 2024;31:3212-3221.
     PubMed     Abstract available
     
     
     
177. GORJI L, Nikahd M, Onuma A, Tsilimigras D, et al
     Comparing Multivisceral Resection with Tumor-only Resection of Liposarcoma Using the Win Ratio.
     Ann Surg Oncol. 2024;31:3389-3396.
     PubMed     Abstract available
     
     
     
178. SHIN JK, Kim HC, Lee WY, Yun SH, et al
     Is Robotic Surgery Beneficial for Rectal Cancer Patients with Unfavorable Characteristic After Neoadjuvant Chemoradiotherapy?
     Ann Surg Oncol. 2024;31:3203-3211.
     PubMed     Abstract available
     
     
     
179. FACKCHE NT, Schmocker RK, Nudotor R, Kubi B, et al
     Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative.
     Ann Surg Oncol. 2024;31:3314-3324.
     PubMed     Abstract available
     
     
     
180. ONO Y, Inoue Y, Kobayashi K, Sato S, et al
     Laparoscopic Portal Vein Ligation and Embolization During First-Stage Hepatectomy for Initially Unresectable Colorectal Liver Metastases.
     Ann Surg Oncol. 2024;31:3069-3070.
     PubMed     Abstract available
     
     
     April 2024
181. STERPETTI AV, Gabriele R, Iannone I, Dimarzo L, et al
     Disparities in Colorectal Cancer Screening.
     Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15296.
     PubMed    
     
     
     
182. BEKKI T, Shimomura M, Yano T, Akabane S, et al
     Reply to Letter to Editor Regarding Article "C-Reactive Protein/Albumin Ratio is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients".
     Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15300.
     PubMed    
     
     
     
183. KHAN MMM, Munir MM, Khalil M, Pawlik TM, et al
     Reply to: Colorectal Cancer Screening and Social Vulnerability Index: Impact of COVID-19 Pandemic.
     Ann Surg Oncol. 2024 Apr 23. doi: 10.1245/s10434-024-15302.
     PubMed    
     
     
     
184. YANG Y, Du Z, Zhang Q
     Letter to Editor regarding article "C-Reactive Protein/Albumin Ratio is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients".
     Ann Surg Oncol. 2024 Apr 10. doi: 10.1245/s10434-024-15263.
     PubMed    
     
     
     
185. BOYEV A, Newhook TE
     ASO Author Reflections: Patients with Recurrence Amenable to Local Therapy for Colorectal Liver Metastases May Experience Improved Survival.
     Ann Surg Oncol. 2024;31:2600-2601.
     PubMed    
     
     
     
186. CHANG WJ, Chen CB, Chang YT, Wen TC, et al
     ASO Author Reflections: Advancements in Laparoscopic Parenchyma-Sparing Liver Resection: Autologous Peritoneal Patch for Middle Hepatic Vein Reconstruction in Colorectal Liver Metastasis.
     Ann Surg Oncol. 2024;31:2598-2599.
     PubMed    
     
     
     
187. CHOI JS, Kim MJ, Shin R, Park JW, et al
     ASO Visual Abstract: Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumor: Who Needs a Radical Resection for the Rectal Neuroendocrine Tumor 1-2 cm in Size?
     Ann Surg Oncol. 2024;31:2439.
     PubMed    
     
     
     
188. WACH MM, Nunns G, Hamed A, Derby J, et al
     Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases.
     Ann Surg Oncol. 2024;31:2391-2400.
     PubMed     Abstract available
     
     
     
189. SAKANAKA T, Iwamoto H, Matsuda K, Mitani Y, et al
     Double Negativity of MRI-Detected and Pathologically-Diagnosed Extramural Venous Invasion is a Favorable Prognostic Factor for Rectal Cancer.
     Ann Surg Oncol. 2024;31:2425-2438.
     PubMed     Abstract available
     
     
     
190. BOYEV A, Tzeng CD, Maki H, Arvide EM, et al
     ASO Visual Abstract: Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases.
     Ann Surg Oncol. 2024;31:2606.
     PubMed    
     
     
     
191. SULLIVAN KM, Whelan RL, DePeralta D, Merchea A, et al
     Reply to Letter to the Editor Concerning "Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the US
     Ann Surg Oncol. 2024;31:2408-2409.
     PubMed    
     
     
     
192. HIRST N, McBride K, Steffens D
     Psychological Interventions in Prehabilitation Randomized Controlled Trials for Patients Undergoing Cancer Surgery: Sufficient or Suboptimal?
     Ann Surg Oncol. 2024;31:2183-2186.
     PubMed    
     
     
     
193. SAKANAKA T, Iwamoto H, Matsuda K, Mitani Y, et al
     ASO Visual Abstract: Double Negativity of MRI-Detected and Pathologically Diagnosed Extramural Venous Invasion is a Favorable Prognostic Factor for Rectal Cancer.
     Ann Surg Oncol. 2024;31:2440-2441.
     PubMed    
     
     
     
194. CHOI JS, Kim MJ, Shin R, Park JW, et al
     Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1-2 cm?
     Ann Surg Oncol. 2024;31:2414-2424.
     PubMed     Abstract available
     
     
     
195. BOYEV A, Tzeng CD, Maki H, Arvide EM, et al
     Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases.
     Ann Surg Oncol. 2024;31:2547-2556.
     PubMed     Abstract available
     
     
     
196. CHIU CC
     Letter to the Editor of Annals of Surgical Oncology Concerning "Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter P
     Ann Surg Oncol. 2024;31:2405-2407.
     PubMed    
     
     
     March 2024
197. KHAN MMM, Munir MM, Woldesenbet S, Endo Y, et al
     ASO Visual Abstract: Association of COVID-19 Pandemic with Colorectal Cancer Screening: Impact of Race/Ethnicity and Social Vulnerability.
     Ann Surg Oncol. 2024 Mar 12. doi: 10.1245/s10434-024-15140.
     PubMed    
     
     
     November 2023
198. SOLBAKKEN AM, Sellevold S, Spasojevic M, Julsrud L, et al
     Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer.
     Ann Surg Oncol. 2023;30:7602-7611.
     PubMed     Abstract available
     
     
     
199. JUDGE SJ, Ghalambor T, Cavnar MJ, Lidsky ME, et al
     Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy: An International Survey of the HAI Consortium Research Network.
     Ann Surg Oncol. 2023;30:7362-7370.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.